SGX:BSLHealthcare
Raffles Medical Group (SGX:BSL) AI Imaging Deal Puts Its Valuation Back In Focus
Raffles Medical Group (SGX:BSL) has drawn attention after signing a supply agreement with Neurophet for Neurophet AQUA, AI driven brain MRI analysis software used in assessing neurodegenerative conditions such as Alzheimer’s disease and vascular dementia.
See our latest analysis for Raffles Medical Group.
At a share price of SGD0.93, Raffles Medical Group has seen a 1 day share price return of 1.09%, while its year to date share price return is down 8.82% and the 1 year total shareholder...